// App-Quantinova.ai

9025 : Nivolumab (nivo) vs docetaxel (doc) in patients (pts) with advanced NSCLC: CheckMate 017/057 2-y update and exploratory cytokine profile analyses.

Researchers

Presenter

  • Hossein Borghaei

Principal Investigators

  • Leora Horn

  • Neal Ready

  • Martin Steins

  • Enriqueta Felip

  • Luis G. Paz-Ares

  • Oscar Arrieta

  • Fabrice Barlesi

  • Scott Joseph Antonia

  • Jerome Fayette

  • Naiyer A. Rizvi

  • Lucio Crino

  • Martin Reck

  • Wilfried Ernst Erich Eberhardt

  • Matthew David Hellmann

  • Kaushal Desai

  • Ang Li

  • Diane I. Healey

  • David R. Spigel

Medical Centers

  • Fox Chase Cancer Center, Philadelphia, PA

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • Vanderbilt University Medical Center, Nashville, TN

  • Duke University Medical Center, Durham, NC

  • Thoraxklinik-Heidelberg gGmbh, Heidelberg, Germany

  • Vall d'Hebron University Hospital, Barcelona, Spain

  • Virgen del Rocio University Hospital, Seville, Spain

  • Instituto Nacional de Cancerologia - INCAN, Mexico City, Mexico

  • Aix-Marseille University, Assistance Publique Hopitaux de Marseille, Marseille, France

  • Moffitt Cancer Center, Tampa, FL

  • Centre Leon Berard, Lyon, France

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Ospedale Di Perugia, Perugia, Italy

  • Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), member of the German Center for Lung Research (DZL), Grosshansdorf, Germany

  • University Hospital - University Duisburg-Essen, Essen, Germany

  • Bristol-Myers Sqiubb, Princeton, NJ

  • Sarah Cannon Research Institute, Nashville, TN

Locations

  • Italy

  • Germany

  • Spain

  • United States

  • Mexico

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

  • Nivolumab

Outcome

  • Unknown

Study Design

  • Single Arm

Phase

  • II

Study Id's

  • NCT01642004

  • NCT01673867

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved